Selected research
Market Analysis & Forecast
Global Anthranilamide Market Analysis and Forecast 2026-2032
Market perspective
The global Anthranilamide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Anthranilamide's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Alchemo Industries as the global sales leader, a title it has maintained for several consecutive years. Notably, Alchemo Industries's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.
The major global manufacturers in the Anthranilamide market include Alchemo Industries, Biosynth, Kavya Pharma and Sarex, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the Anthranilamide production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of Anthranilamide by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for Anthranilamide, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Anthranilamide, also provides the consumption of main regions and countries. Of the upcoming market potential for Anthranilamide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anthranilamide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anthranilamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anthranilamide sales, projected growth trends, production technology, application and end-user industry.
Anthranilamide Segment by Company
Alchemo Industries
Biosynth
Kavya Pharma
Sarex
Anthranilamide Segment by Type
0.99
0.98
Anthranilamide Segment by Application
Medicine
Spices
Pesticide
Chemical
Others
Anthranilamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anthranilamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anthranilamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anthranilamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Anthranilamide production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Anthranilamide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Anthranilamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anthranilamide sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.99
- 0.98
Applications
- Medicine
- Spices
- Pesticide
- Chemical
- Others
Companies covered
- Alchemo Industries
- Biosynth
- Kavya Pharma
- Sarex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Anthranilamide Market by Type
- 1.2.1 Global Anthranilamide Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 0.99
- 1.2.3 0.98
- 1.3 Anthranilamide Market by Application
- 1.3.1 Global Anthranilamide Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medicine
- 1.3.3 Spices
- 1.3.4 Pesticide
- 1.3.5 Chemical
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Anthranilamide Market Dynamics
- 2.1 Anthranilamide Industry Trends
- 2.2 Anthranilamide Industry Drivers
- 2.3 Anthranilamide Industry Opportunities and Challenges
- 2.4 Anthranilamide Industry Restraints
3 Global Anthranilamide Production Overview
- 3.1 Global Anthranilamide Production Capacity (2021-2032)
- 3.2 Global Anthranilamide Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Anthranilamide Production by Region
- 3.3.1 Global Anthranilamide Production by Region (2021-2026)
- 3.3.2 Global Anthranilamide Production by Region (2027-2032)
- 3.3.3 Global Anthranilamide Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global Anthranilamide Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Anthranilamide Revenue by Region
- 4.2.1 Global Anthranilamide Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Anthranilamide Revenue by Region (2021-2026)
- 4.2.3 Global Anthranilamide Revenue by Region (2027-2032)
- 4.2.4 Global Anthranilamide Revenue Market Share by Region (2021-2032)
- 4.3 Global Anthranilamide Sales Estimates and Forecasts 2021-2032
- 4.4 Global Anthranilamide Sales by Region
- 4.4.1 Global Anthranilamide Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Anthranilamide Sales by Region (2021-2026)
- 4.4.3 Global Anthranilamide Sales by Region (2027-2032)
- 4.4.4 Global Anthranilamide Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Anthranilamide Revenue by Manufacturers
- 5.1.1 Global Anthranilamide Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Anthranilamide Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Anthranilamide Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Anthranilamide Sales by Manufacturers
- 5.2.1 Global Anthranilamide Sales by Manufacturers (2021-2026)
- 5.2.2 Global Anthranilamide Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Anthranilamide Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Anthranilamide Sales Price by Manufacturers (2021-2026)
- 5.4 Global Anthranilamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Anthranilamide Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Anthranilamide Manufacturers, Product Type & Application
- 5.7 Global Anthranilamide Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Anthranilamide Market CR5 and HHI
- 5.8.2 2025 Anthranilamide Tier 1, Tier 2, and Tier 3
6 Anthranilamide Market by Type
- 6.1 Global Anthranilamide Revenue by Type
- 6.1.1 Global Anthranilamide Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Anthranilamide Revenue Market Share by Type (2021-2032)
- 6.2 Global Anthranilamide Sales by Type
- 6.2.1 Global Anthranilamide Sales by Type (2021-2032) & (Tons)
- 6.2.2 Global Anthranilamide Sales Market Share by Type (2021-2032)
- 6.3 Global Anthranilamide Price by Type
7 Anthranilamide Market by Application
- 7.1 Global Anthranilamide Revenue by Application
- 7.1.1 Global Anthranilamide Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Anthranilamide Revenue Market Share by Application (2021-2032)
- 7.2 Global Anthranilamide Sales by Application
- 7.2.1 Global Anthranilamide Sales by Application (2021-2032) & (Tons)
- 7.2.2 Global Anthranilamide Sales Market Share by Application (2021-2032)
- 7.3 Global Anthranilamide Price by Application
8 Company Profiles
- 8.1 Alchemo Industries
- 8.1.1 Alchemo Industries Company Information
- 8.1.2 Alchemo Industries Business Overview
- 8.1.3 Alchemo Industries Anthranilamide Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Alchemo Industries Anthranilamide Product Portfolio
- 8.1.5 Alchemo Industries Recent Developments
- 8.2 Biosynth
- 8.2.1 Biosynth Company Information
- 8.2.2 Biosynth Business Overview
- 8.2.3 Biosynth Anthranilamide Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Biosynth Anthranilamide Product Portfolio
- 8.2.5 Biosynth Recent Developments
- 8.3 Kavya Pharma
- 8.3.1 Kavya Pharma Company Information
- 8.3.2 Kavya Pharma Business Overview
- 8.3.3 Kavya Pharma Anthranilamide Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Kavya Pharma Anthranilamide Product Portfolio
- 8.3.5 Kavya Pharma Recent Developments
- 8.4 Sarex
- 8.4.1 Sarex Company Information
- 8.4.2 Sarex Business Overview
- 8.4.3 Sarex Anthranilamide Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Sarex Anthranilamide Product Portfolio
- 8.4.5 Sarex Recent Developments
9 North America
- 9.1 North America Anthranilamide Market Size by Type
- 9.1.1 North America Anthranilamide Revenue by Type (2021-2032)
- 9.1.2 North America Anthranilamide Sales by Type (2021-2032)
- 9.1.3 North America Anthranilamide Price by Type (2021-2032)
- 9.2 North America Anthranilamide Market Size by Application
- 9.2.1 North America Anthranilamide Revenue by Application (2021-2032)
- 9.2.2 North America Anthranilamide Sales by Application (2021-2032)
- 9.2.3 North America Anthranilamide Price by Application (2021-2032)
- 9.3 North America Anthranilamide Market Size by Country
- 9.3.1 North America Anthranilamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Anthranilamide Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Anthranilamide Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Anthranilamide Market Size by Type
- 10.1.1 Europe Anthranilamide Revenue by Type (2021-2032)
- 10.1.2 Europe Anthranilamide Sales by Type (2021-2032)
- 10.1.3 Europe Anthranilamide Price by Type (2021-2032)
- 10.2 Europe Anthranilamide Market Size by Application
- 10.2.1 Europe Anthranilamide Revenue by Application (2021-2032)
- 10.2.2 Europe Anthranilamide Sales by Application (2021-2032)
- 10.2.3 Europe Anthranilamide Price by Application (2021-2032)
- 10.3 Europe Anthranilamide Market Size by Country
- 10.3.1 Europe Anthranilamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Anthranilamide Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Anthranilamide Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Anthranilamide Market Size by Type
- 11.1.1 China Anthranilamide Revenue by Type (2021-2032)
- 11.1.2 China Anthranilamide Sales by Type (2021-2032)
- 11.1.3 China Anthranilamide Price by Type (2021-2032)
- 11.2 China Anthranilamide Market Size by Application
- 11.2.1 China Anthranilamide Revenue by Application (2021-2032)
- 11.2.2 China Anthranilamide Sales by Application (2021-2032)
- 11.2.3 China Anthranilamide Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Anthranilamide Market Size by Type
- 12.1.1 Asia Anthranilamide Revenue by Type (2021-2032)
- 12.1.2 Asia Anthranilamide Sales by Type (2021-2032)
- 12.1.3 Asia Anthranilamide Price by Type (2021-2032)
- 12.2 Asia Anthranilamide Market Size by Application
- 12.2.1 Asia Anthranilamide Revenue by Application (2021-2032)
- 12.2.2 Asia Anthranilamide Sales by Application (2021-2032)
- 12.2.3 Asia Anthranilamide Price by Application (2021-2032)
- 12.3 Asia Anthranilamide Market Size by Country
- 12.3.1 Asia Anthranilamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Anthranilamide Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Anthranilamide Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Anthranilamide Market Size by Type
- 13.1.1 SAMEA Anthranilamide Revenue by Type (2021-2032)
- 13.1.2 SAMEA Anthranilamide Sales by Type (2021-2032)
- 13.1.3 SAMEA Anthranilamide Price by Type (2021-2032)
- 13.2 SAMEA Anthranilamide Market Size by Application
- 13.2.1 SAMEA Anthranilamide Revenue by Application (2021-2032)
- 13.2.2 SAMEA Anthranilamide Sales by Application (2021-2032)
- 13.2.3 SAMEA Anthranilamide Price by Application (2021-2032)
- 13.3 SAMEA Anthranilamide Market Size by Country
- 13.3.1 SAMEA Anthranilamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Anthranilamide Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Anthranilamide Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Anthranilamide Value Chain Analysis
- 14.1.1 Anthranilamide Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Anthranilamide Production Mode & Process
- 14.2 Anthranilamide Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Anthranilamide Distributors
- 14.2.3 Anthranilamide Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst